Sale!

PAX4 Gene Maturity-onset Diabetes of the Young Type 9 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PAX4 Gene Maturity-onset Diabetes of the Young Type 9 (MODY9) Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the PAX4 gene, which are associated with MODY9. This condition is a form of diabetes that typically manifests in adolescence or early adulthood and is characterized by a dysfunction in insulin production. Unlike other forms of diabetes, MODY9 is primarily influenced by genetic factors rather than lifestyle or environmental conditions.

The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect the presence of specific genetic mutations in the PAX4 gene. The identification of these mutations can help in confirming a diagnosis of MODY9, allowing for personalized treatment plans that are more effective and tailored to the individual’s genetic makeup.

The cost of the PAX4 Gene Maturity-onset Diabetes of the Young Type 9 Genetic Test at DNA Labs UAE is 4400 AED. This investment in diagnostic testing can be crucial for affected individuals and their families to manage the condition effectively, enabling a better quality of life and reducing the risk of complications associated with diabetes. Early diagnosis and intervention are key in managing MODY9, making this test an invaluable resource for those with a family history of the condition or who exhibit symptoms suggestive of this type of diabetes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PAX4 Gene Maturity-onset diabetes of the young type 9 Genetic Test

Test Details

The PAX4 gene is a gene that provides instructions for making a protein called PAX4 transcription factor. This protein plays a crucial role in the development and function of beta cells in the pancreas, which are responsible for producing and regulating the release of insulin.

Maturity-onset diabetes of the young type 9 (MODY9) is a rare form of diabetes that is caused by mutations in the PAX4 gene. These mutations disrupt the normal function of the PAX4 protein, leading to impaired insulin production and secretion.

MODY9 is typically characterized by early-onset diabetes, often before the age of 25, and is usually inherited in an autosomal dominant manner, meaning that a mutation in only one copy of the PAX4 gene is sufficient to cause the condition.

Test Name

PAX4 Gene Maturity-onset diabetes of the young type 9 Genetic Test

Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for PAX4 Gene Maturity-onset diabetes of the young type 9 NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with Maturity-onset diabetes of the young type 9

Test Details

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of MODY9, NGS genetic testing can be used to identify mutations in the PAX4 gene that are associated with the condition.

This testing can help confirm a diagnosis of MODY9 in individuals with suspected or early-onset diabetes and can also be used for genetic counseling and family planning purposes.

It is important to note that genetic testing for MODY9 and other forms of MODY should be performed by healthcare professionals with expertise in genetic testing and interpretation, as the results can have significant implications for patient management and treatment decisions.

Test Name PAX4 Gene Maturity-onset diabetes of the young type 9 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PAX4 Gene Maturity-onset diabetes of the young type 9 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Maturity-onset diabetes of the young type 9
Test Details

The PAX4 gene is a gene that provides instructions for making a protein called PAX4 transcription factor. This protein plays a crucial role in the development and function of beta cells in the pancreas, which are responsible for producing and regulating the release of insulin.

Maturity-onset diabetes of the young type 9 (MODY9) is a rare form of diabetes that is caused by mutations in the PAX4 gene. These mutations disrupt the normal function of the PAX4 protein, leading to impaired insulin production and secretion. MODY9 is typically characterized by early-onset diabetes, often before the age of 25, and is usually inherited in an autosomal dominant manner, meaning that a mutation in only one copy of the PAX4 gene is sufficient to cause the condition.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of MODY9, NGS genetic testing can be used to identify mutations in the PAX4 gene that are associated with the condition. This testing can help confirm a diagnosis of MODY9 in individuals with suspected or early-onset diabetes and can also be used for genetic counseling and family planning purposes.

It is important to note that genetic testing for MODY9 and other forms of MODY should be performed by healthcare professionals with expertise in genetic testing and interpretation, as the results can have significant implications for patient management and treatment decisions.